Download

Download eBook for Free

FormatFile SizeNotes
PDF file 4.6 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Purchase

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback215 pages $28.00 $22.40 20% Web Discount

This study aims to identify which medications deserve priority for clinical research in the short term. The authors found that a lot of knowledge is already available and needs dissemination rather than further research. The medication for ADHD, Ritalin is the best example of this. However, many medications have not been studied yet in children and among those, two research questions are identified: 1 - clinical research on the safety, effectiveness and long term effects of (amongst others) psycho-active substances, new anti-epileptics and gastro-intestinal medications for use in children 2 - dissemination of knowledge on several medications to paediatricians, general practitioners and pharmacists.

Table of Contents

  • Summary

  • Preface

    All Prefatory Materials

  • Chapter 1

    Inleiding

  • Chapter 2

    Methodologie

  • Chapter 3

    Resultaten

  • Nawoord

  • Literatuurlijst

  • Appendix A

    Lijst GeÏNterviewden

  • Appendix B

    Schriftelijke Vragenlijst

  • Appendix C

    Analyse Schriftelijke Vragenlijst

  • Appendix D

    Interviewprotocol

  • Appendix E

    Scorelijst Inhoudelijke Commissie

  • Appendix F

    Literatuuronderzoek

Research conducted by

The research described in this report was performed under the auspices of RAND Europe.

This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.